Skip to main content
Clinical Trials/NCT03703037
NCT03703037
Completed
Not Applicable

Clinical Utility of Uterine, Fetal Cerebral Doppler and Oligohydramnios to Predict Abnormal Heart Rate Tracings in Pregnancies at or Beyond 41 Weeks

Hospital Universitario Dr. Jose E. Gonzalez1 site in 1 country227 target enrollmentJanuary 1, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Abnormality in Fetal Heart Rate or Rhythm
Sponsor
Hospital Universitario Dr. Jose E. Gonzalez
Enrollment
227
Locations
1
Primary Endpoint
Category III fetal heart rate tracings
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Objective: To estimate the value of uterine, fetal cerebral Doppler and oligohydramnios to predict abnormal fetal heart rate tracings in pregnancies at or beyond 41 weeks

Detailed Description

This will be a nested case-control study that was conducted at University Hospital Dr. Jose E. Gonzalez after the approval of Institutional ethical committee. Women with low risk late term or postterm pregnancy (at least 41 weeks) with confirm gestational age who will be referred to our Maternal-fetal unit and admitted 1 to 2 days prior to induction of labour according institutional protocol will be recruited and constitute the cohort. Cases will be patients with abnormal intrapartum cardiotocogram (category III fetal heart rate tracing). For each case, four controls will be matched. The primary outcome will be to obtain odds ratios for the Doppler parameters (middle cerebral artery pulsatility index, mean uterine artery pulsatility index and Middle cerebral artery pulsatility index to mean uterine artery pulsatility index ratio) and amniotic fluid index that would be associated with intrapartum category III fetal heart rate tracing.

Registry
clinicaltrials.gov
Start Date
January 1, 2016
End Date
October 1, 2019
Last Updated
6 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Hospital Universitario Dr. Jose E. Gonzalez
Responsible Party
Principal Investigator
Principal Investigator

Flavio Hernández Castro

Principal investigator Flavio Hernández Castro MD PhD

Hospital Universitario Dr. Jose E. Gonzalez

Eligibility Criteria

Inclusion Criteria

  • Singleton pregnancy
  • Gestational age of at least 287 days (41 weeks)
  • Low risk pregnancy (defined as the absence of maternal or fetal complications other than postterm pregnancy)

Exclusion Criteria

  • Twin or multiple gestation
  • Uncertain gestational age
  • Non vertex presentation
  • Estimated fetal weight below the 10th percentile for gestational age (Hadlock´s formula)
  • Fetal macrosomia (estimated fetal weight ≥ 4 Kilos) diagnosed by clinical measurement (Johnson´s technique) or ultrasound measurement (Hadlock´s formula).
  • Fetal abnormalities found on routine anomaly scan.
  • Maternal medical disorder (preeclampsia, chronic hypertension, diabetes, lupus, hyperthyroidism)
  • Prelabour rupture of membranes
  • Antepartum hemorrhage
  • Any fetopelvic disproportion that could create dystocia during labor.

Outcomes

Primary Outcomes

Category III fetal heart rate tracings

Time Frame: 24 hours

Absent baseline fetal heart rate variability and any of the following: recurrent late decelerations, recurrent variable decelerations, bradycardia, sinusoidal pattern

Secondary Outcomes

  • Middle cerebral artery pulsatility index to mean uterine artery pulsatility index ratio(24 hours before delivery)
  • Middle cerebral artery pulsatility index(24 hours before delivery)
  • Oligohydramnios(24 hours before delivery)
  • Mean uterine artery pulsatility index(24 hours before delivery)

Study Sites (1)

Loading locations...

Similar Trials